临床病理参数 | N | Galectin-3 | χ2 | P | Foxp3 | χ2 | P | IL-17A | χ2 | P | ||||
(−) | (+) | (−) | (+) | (−) | (+) | |||||||||
性别 | 男 | 27 | 6 | 21 | 3.628 | 0.076 | 14 | 13 | 3.435 | 0.064 | 4 | 23 | 2.715 | 0.183 |
| 女 | 23 | 11 | 12 |
|
| 6 | 17 |
|
| 8 | 15 |
|
|
年龄 | ≤55岁 | 17 | 7 | 10 | 0.591 | 0.534 | 8 | 9 | 0.535 | 0.548 | 5 | 12 | 0.414 | 0.728 |
| >55岁 | 33 | 10 | 23 |
|
| 12 | 21 |
|
| 7 | 26 |
|
|
部位 | 右半结肠 | 30 | 10 | 20 | 0.015 | 0.903 | 12 | 18 | 0.001 | 1.000 | 8 | 22 | 0.292 | 0.740 |
| 左半结肠 | 20 | 7 | 13 |
|
| 8 | 12 |
|
| 4 | 16 |
|
|
最大径 | <5 cm | 30 | 13 | 17 | 2.911 | 0.088 | 13 | 17 | 0.347 | 0.769 | 8 | 22 | 0.292 | 0.740 |
| ≥5 cm | 20 | 4 | 16 |
|
| 7 | 13 |
|
| 4 | 16 |
|
|
分化程度 | 中高分化 | 36 | 14 | 22 | 1.369 | 0.242 | 13 | 23 | 0.810 | 0.522 | 10 | 26 | 1.006 | 0.468 |
| 低分化 | 14 | 3 | 11 |
|
| 7 | 7 |
|
| 2 | 12 |
|
|
浸润深度 | T1-T2 | 13 | 7 | 6 | 3.083 | 0.079 | 5 | 8 | 0.017 | 1.000 | 5 | 8 | 2.014 | 0.256 |
| T3-T4 | 37 | 10 | 27 |
|
| 15 | 22 |
|
| 7 | 30 |
|
|
TNM分期 | I~II | 26 | 14 | 12 | 9.507 | 0.002 | 17 | 9 | 8.194 | 0.005 | 12 | 14 | 4.987 | 0.035 |
| III~IV | 24 | 3 | 21 |
|
| 6 | 18 |
|
| 4 | 20 |
|
|
术前CEA | CEA < 5 | 22 | 9 | 13 | 0.836 | 0.386 | 10 | 12 | 0.487 | 0.567 | 4 | 18 | 0.729 | 0.512 |
| CEA > 5 | 28 | 8 | 20 |
|
| 10 | 18 |
|
| 8 | 20 |
|
|
组织性质 | 癌 | 50 | 17 | 33 | 10.643 | 0.001 | 20 | 30 | 8.343 | 0.005 | 12 | 38 | 11.760 | 0.001 |
| 正常 | 10 | 9 | 1 |
|
| 9 | 1 |
|
| 8 | 2 |
|
|